Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Hip Reconstruction or Hip Replacement is an intervention which involves replacement of the damaged or diseased parts of the hip joint. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hip reconstruction market in Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hip reconstruction market in Japan was Zimmer Biomet followed by Stryker, DePuy Synthes, Kyocera Medical Technologies, Smith & Nephew, Medacta Group, Limacorporate, Exactech, United Orthopedic, B. Braun Melsungen and MicroPort Scientific.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The Hip Reconstruction includes devices (implants) used in the hip replacement interventions. A Hip Replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. Modern artificial hip joints are generally designed to last for 15 years or more.
The hip reconstruction market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size hip reconstruction in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
